How is the Renovaro Biosciences Inc today?

The Renovaro Biosciences Inc today is trading in the down by -17.14% at 0.29.

What is Renovaro Biosciences Inc Annual Net Profit?

Renovaro Biosciences Inc Annual Net Profit fell 122.82% in the last year to $88.43 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Renovaro Biosciences Inc Price to Earning Ratio?

Renovaro Biosciences Inc Price to Earning Ratio is -0.74, which is negative.

What is Renovaro Biosciences Inc Stock Price?

Renovaro Biosciences Inc Stock Price fell 80.67% and underperformed its sector by 115.54% in the past year.

What is Renovaro Biosciences Inc Quarterly Net profit?

Renovaro Biosciences Inc Quarterly Net profit rose 100.32% YoY to $0.19 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is Renovaro Biosciences Inc Debt to Equity Ratio?

Renovaro Biosciences Inc Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Renovaro Biosciences Inc Return on Equity(ROE)?

Renovaro Biosciences Inc Return on Equity(ROE) for the last financial year was -99.09%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Renovaro Biosciences Inc Mutual Fund Holding?

Renovaro Biosciences Inc Mutual Fund Holding decreased by 0.7% in the last quarter to 12.62.

What is Renovaro Biosciences Inc Promoter Share Holding?

Renovaro Biosciences Inc Promoter Share Holding stayed the same in the most recent quarter at 1.08%.

What is Renovaro Biosciences Inc Interest Coverage Ratio?

Renovaro Biosciences Inc Interest Coverage Ratio is -35.32, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Renovaro Biosciences Inc Institutional Holding?

Renovaro Biosciences Inc Institutional Holding decreased by 0.47% in the last quarter to 12.9.

Renovaro Biosciences Inc XNAS: RENB

Renovaro Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Renovaro Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Renovaro Biosciences Inc
Rating: 0.87741675
Author: Trendlyne DVM scores

about

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

0.29 -0.06 (-17.14%)

86.19% Fall from 52W High

13.2M

XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

14.2 / 100

Technically Bearish

20.9 / 100

No estimates available

Renovaro Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Renovaro Biosciences Inc FAQ

How is Renovaro Biosciences Inc today?

Renovaro Biosciences Inc today is trading in the red, and is down by -17.14% at 0.29.

How has Renovaro Biosciences Inc performed historically?

Renovaro Biosciences Inc is currently trading down -17.14% on an intraday basis. In the past week the stock fell -14.71%. stock has been down -55.38% in the past quarter and fell -80.67% in the past year. You can view this in the overview section.